Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells

R. Zarrilli, S. Pignata, M. Romano, A. Gravina, S. Casola, C. B. Bruni, A. M. Acquaviva

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

We have studied the expression of insulin-like growth factor type II (IGF- II) and its autocrine role during the proliferation and differentiation of the CaCo-2 colon carcinoma cell line. IGF-II RNA levels were high in proliferating cells and decreased by more than 10-fold when cells ceased to proliferate and differentiated. Immunoreactive IGF-II protein was high in the conditioned media of proliferating cells and decreased 20-fold in the media of differentiated cells. Reduced IGF-II expression was associated with a decrease in IGF-I receptor number that was high in proliferating cells (approximately 80,000 binding sites/cell) and reduced by 4-fold in differentiated cells. Exogenously added IGF-II was able to stimulate proliferation of serum-deprived cells in a dose-dependent fashion. IGF-II acted through the IGF-I receptor, since both basal and IGF-II-stimulated cell proliferation was inhibited by the monoclonal antibody α-IR3, which blocks the binding sites of the IGF-I receptor. The inhibition of CaCo-2 basal cell growth by the α-IR3 antibody suggests that IGF-II may act as an autocrine growth factor for these cells.

Original languageEnglish
Pages (from-to)1085-1091
Number of pages7
JournalCell Growth and Differentiation
Volume5
Issue number10
Publication statusPublished - 1994

Fingerprint

IGF Type 1 Receptor
Insulin-Like Growth Factor II
Colon
Carcinoma
Binding Sites
Caco-2 Cells
Conditioned Culture Medium
Intercellular Signaling Peptides and Proteins
Monoclonal Antibodies
Cell Proliferation
RNA
Cell Line
Antibodies

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells. / Zarrilli, R.; Pignata, S.; Romano, M.; Gravina, A.; Casola, S.; Bruni, C. B.; Acquaviva, A. M.

In: Cell Growth and Differentiation, Vol. 5, No. 10, 1994, p. 1085-1091.

Research output: Contribution to journalArticle

@article{4d0c4d082c7248f69a90f78b2c3dca3b,
title = "Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells",
abstract = "We have studied the expression of insulin-like growth factor type II (IGF- II) and its autocrine role during the proliferation and differentiation of the CaCo-2 colon carcinoma cell line. IGF-II RNA levels were high in proliferating cells and decreased by more than 10-fold when cells ceased to proliferate and differentiated. Immunoreactive IGF-II protein was high in the conditioned media of proliferating cells and decreased 20-fold in the media of differentiated cells. Reduced IGF-II expression was associated with a decrease in IGF-I receptor number that was high in proliferating cells (approximately 80,000 binding sites/cell) and reduced by 4-fold in differentiated cells. Exogenously added IGF-II was able to stimulate proliferation of serum-deprived cells in a dose-dependent fashion. IGF-II acted through the IGF-I receptor, since both basal and IGF-II-stimulated cell proliferation was inhibited by the monoclonal antibody α-IR3, which blocks the binding sites of the IGF-I receptor. The inhibition of CaCo-2 basal cell growth by the α-IR3 antibody suggests that IGF-II may act as an autocrine growth factor for these cells.",
author = "R. Zarrilli and S. Pignata and M. Romano and A. Gravina and S. Casola and Bruni, {C. B.} and Acquaviva, {A. M.}",
year = "1994",
language = "English",
volume = "5",
pages = "1085--1091",
journal = "Cell Growth and Differentiation",
issn = "1044-9523",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Expression of insulin-like growth factor (IGF)-II and IGF-I receptor during proliferation and differentiation of CaCo-2 human colon carcinoma cells

AU - Zarrilli, R.

AU - Pignata, S.

AU - Romano, M.

AU - Gravina, A.

AU - Casola, S.

AU - Bruni, C. B.

AU - Acquaviva, A. M.

PY - 1994

Y1 - 1994

N2 - We have studied the expression of insulin-like growth factor type II (IGF- II) and its autocrine role during the proliferation and differentiation of the CaCo-2 colon carcinoma cell line. IGF-II RNA levels were high in proliferating cells and decreased by more than 10-fold when cells ceased to proliferate and differentiated. Immunoreactive IGF-II protein was high in the conditioned media of proliferating cells and decreased 20-fold in the media of differentiated cells. Reduced IGF-II expression was associated with a decrease in IGF-I receptor number that was high in proliferating cells (approximately 80,000 binding sites/cell) and reduced by 4-fold in differentiated cells. Exogenously added IGF-II was able to stimulate proliferation of serum-deprived cells in a dose-dependent fashion. IGF-II acted through the IGF-I receptor, since both basal and IGF-II-stimulated cell proliferation was inhibited by the monoclonal antibody α-IR3, which blocks the binding sites of the IGF-I receptor. The inhibition of CaCo-2 basal cell growth by the α-IR3 antibody suggests that IGF-II may act as an autocrine growth factor for these cells.

AB - We have studied the expression of insulin-like growth factor type II (IGF- II) and its autocrine role during the proliferation and differentiation of the CaCo-2 colon carcinoma cell line. IGF-II RNA levels were high in proliferating cells and decreased by more than 10-fold when cells ceased to proliferate and differentiated. Immunoreactive IGF-II protein was high in the conditioned media of proliferating cells and decreased 20-fold in the media of differentiated cells. Reduced IGF-II expression was associated with a decrease in IGF-I receptor number that was high in proliferating cells (approximately 80,000 binding sites/cell) and reduced by 4-fold in differentiated cells. Exogenously added IGF-II was able to stimulate proliferation of serum-deprived cells in a dose-dependent fashion. IGF-II acted through the IGF-I receptor, since both basal and IGF-II-stimulated cell proliferation was inhibited by the monoclonal antibody α-IR3, which blocks the binding sites of the IGF-I receptor. The inhibition of CaCo-2 basal cell growth by the α-IR3 antibody suggests that IGF-II may act as an autocrine growth factor for these cells.

UR - http://www.scopus.com/inward/record.url?scp=0028131791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028131791&partnerID=8YFLogxK

M3 - Article

C2 - 7848910

AN - SCOPUS:0028131791

VL - 5

SP - 1085

EP - 1091

JO - Cell Growth and Differentiation

JF - Cell Growth and Differentiation

SN - 1044-9523

IS - 10

ER -